본문 바로가기 주메뉴 바로가기

Company

History

Company History Onselex
2022
  • Oct. 12,2022 Professor Si-young Song, Distinguished Professor and Clinician at Yonsei University College of Medicine joined as a member of Onselex CAB
  • Oct. 06,2022 Professor Hosoon Choi, Chief at Hanyang University Medical Center joined as a member of Onselex CAB
  • July. 04,2022 In the PK test of the ONX-1006 PANC-1 Xenograft mouse model, higher PTX was detected in the tumor tissue compared to the plasma.
  • Mar. 30,2022 ONX-1006 anticancer drug, Beagle single IV administration toxicity GLP test: Confirmation of Beagle in the normal and safe state even after administration of 3 times the lethal dose of ONX-1006 (PTX 25mg/kg).
  • Mar. 3,2022 Study for Anti-Tumor Effect of ONX-1006 on Tumor Growth Formed by AsPC-1 Carcinoma Cells, 5th successful statically significant Efficacy results achieved
2021
  • Dec. 14, 2021 ONX-1006 GLP anticancer test (intravenous administration of rats) : Confirmation of rats in a normal and safe state after administration of 20 times the lethal dose of the paclitaxel
  • Oct. 06, 2021 Completed development of ONX-2006 anticancer drug (Pills) : stomach cancer, colon cancer
  • Sept. 27, 2021 ONX-1006 AsPC-1 Pancreatic Cancer Cell Xenograft Model 3rd successful Efficacy results achieved
  • Aug. 10, 2021 Initiated 3rd ONX-1006 Xenograft efficacy test (with Dt&C)
  • Mar. 30, 2021 Completed for entry into the national phase of the PCT international patent application
2020
  • Dec. 16, 2020 Signed MDA-MB-231 xenograft ONX-1006 Breast cancer efficacy test with ChemOn
  • Aug. 31, 2020 Signed a Pre-clinical trial agreement of ONX-1006
  • Aug. 27, 2020 Signed an agreement for non-clinical trials of ONX-1006 oncologic efficacy
  • Aug. 25, 2020 Paid-in capital increase by allocation to third parties (Founding capital : KRW 1,628,656,000, Total amount of investment on 28,656 , new shares: KRW 2,579,040,000)
  • Jul. 13, 2020 Signed an exclusive Global Nano Cancer Licensing Agreement
  • Jul. 10, 2020 Completed the mass production of the GLP ONX-1006 in kilogram scale
  • Jul. 1, 2020 Signed a technology transfer agreement for Programmed Nanoparticle – Loaded Drug
  • Mar. 19, 2020 Founding of company